Intensity-modulated radiotherapy in the treatment of head and neck cancer.

[1]  P. Warde,et al.  Intensity-modulated radiotherapy in the treatment of breast cancer. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

[2]  Walter R. Bosch,et al.  Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). , 2010, International journal of radiation oncology, biology, physics.

[3]  D. Moore,et al.  Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Garden,et al.  Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  K. Harrington,et al.  First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537). , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  W. De Neve,et al.  Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. , 2009, International journal of radiation oncology, biology, physics.

[7]  A. McMillan,et al.  A Randomized Trial Comparing Intensity Modulated Radiotherapy versus 2-Dimensional Radiotherapy for Stage II Nasopharyngeal Carcinoma , 2008 .

[8]  J. Shah,et al.  Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. , 2008, International journal of radiation oncology, biology, physics.

[9]  N. Lee,et al.  Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.

[10]  J. Buatti,et al.  Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. , 2007, International journal of radiation oncology, biology, physics.

[11]  P. Harari,et al.  Are we influencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison. , 2007, International journal of radiation oncology, biology, physics.

[12]  S. Leung,et al.  Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Kaplan,et al.  Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? , 2007, International journal of radiation oncology, biology, physics.

[14]  D. Rades,et al.  Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. , 2007, Oral oncology.

[15]  K. Vineberg,et al.  Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. , 2007, International journal of radiation oncology, biology, physics.

[16]  J. Bourhis,et al.  Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[17]  F. Fang,et al.  Intensity‐modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma , 2007, Cancer.

[18]  C. Terhaard,et al.  Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[19]  Suzanne L Wolden,et al.  A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[20]  J. Sham,et al.  Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.

[21]  S. Burri,et al.  Radiation-Induced trismus in head and neck cancer patients , 2006, Supportive Care in Cancer.

[22]  G. Studer,et al.  Osteoradionecrosis of the Mandible , 2006, Strahlentherapie und Onkologie.

[23]  C. Tsien,et al.  Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. , 2005, International journal of radiation oncology, biology, physics.

[24]  F. Claus,et al.  Postoperative intensity‐modulated radiotherapy in sinonasal carcinoma , 2005, Cancer.

[25]  L. Dawson,et al.  Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. , 2004, International journal of radiation oncology, biology, physics.

[26]  P. Warde,et al.  Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  P. Xia,et al.  Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. , 2001, International journal of radiation oncology, biology, physics.

[28]  P. Xia,et al.  Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. , 2000, International journal of radiation oncology, biology, physics.

[29]  M K Martel,et al.  Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. , 2000, International journal of radiation oncology, biology, physics.

[30]  A Gafni,et al.  The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  Radiation Oncology BioMed Central , 2008 .

[32]  D. Sackett.  Evidence-based medicine: how to practice and teach EBM: 2nd ed , 2000 .